We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
651
Cisco
CSCO
$452B
$2.52M 0.02%
36,385
-220
-0.6% -$13.5K
NPK icon
652
National Presto Industries
NPK
$893M
$2.52M 0.02%
25,752
+2
+0% +$175
UBER icon
653
Uber
UBER
$139B
$2.5M 0.02%
26,750
+1,750
+7% +$144K
NOMD icon
654
Nomad Foods
NOMD
$1.67B
$2.48M 0.02%
146,082
+5,000
+4% +$91.8K
KKR.PRD
655
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.24B
$2.47M 0.02%
46,000
– –
CTGO icon
656
Contango Silver & Gold Inc
CTGO
$550M
$2.46M 0.02%
126,479
– –
TKC icon
657
Turkcell
TKC
$4.79B
$2.45M 0.02%
405,500
-500
-0.1% -$3.04K
AB icon
658
AllianceBernstein
AB
$3.54B
$2.45M 0.02%
60,000
-135,000
-69% -$5.29M
IVZ icon
659
Invesco
IVZ
$13.4B
$2.44M 0.02%
155,000
– –
LWAY icon
660
Lifeway Foods
LWAY
$469M
$2.43M 0.02%
98,644
+33,988
+53% +$805K
LASR icon
661
nLIGHT
LASR
$3.8B
$2.43M 0.02%
+123,454
New +$1.53M
ESI icon
662
Element Solutions
ESI
$9.02B
$2.42M 0.02%
107,000
– –
SRG
663
Seritage Growth Properties
SRG
$132M
$2.41M 0.02%
781,328
-3,000
-0.4% -$8.64K
WAT icon
664
Waters Corp
WAT
$36.6B
$2.39M 0.02%
6,850
-200
-3% -$68.8K
MOS icon
665
The Mosaic Company
MOS
$7.05B
$2.39M 0.02%
65,400
+8,900
+16% +$285K
MLAB icon
666
Mesa Laboratories
MLAB
$537M
$2.37M 0.02%
+25,156
New +$2.76M
EHC icon
667
Encompass Health
EHC
$11.3B
$2.36M 0.02%
+19,260
New +$2.2M
CHRD icon
668
Chord Energy
CHRD
$7.51B
$2.36M 0.02%
+24,331
New +$2.32M
SAND
669
DELISTED
Sandstorm Gold
SAND
$2.35M 0.02%
+250,000
New +$2.14M
AESI icon
670
Atlas Energy Solutions
AESI
$1.45B
$2.33M 0.02%
+173,926
New +$2.38M
PHM icon
671
Pultegroup
PHM
$24.7B
$2.32M 0.02%
22,000
– –
KD icon
672
Kyndryl
KD
$2.82B
$2.32M 0.02%
55,284
-7,000
-11% -$253K
SON icon
673
Sonoco
SON
$5.82B
$2.32M 0.02%
53,200
– –
ALIT icon
674
Alight
ALIT
$531M
$2.31M 0.02%
20,446
+13,628
+200% +$1.46M
ETR icon
675
Entergy
ETR
$53.2B
$2.29M 0.02%
27,550
-1,000
-4% -$82.6K
25 26
27
28 29

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.